Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Connect Twitter with Market Wire News

TRIL - Trillium Therapeutics Stock Trading

home / stock / tril

Trillium Therapeutics Inc.(NASDAQ: TRIL) stock trading, description, contact, officers and directors.
About Trillium Therapeutics Inc.
Trillium Therapeutics Inc. is an immuno oncology company developing innovative therapies for the treatment of cancer. The Company has two premier preclinical programs, SIRPaFc and a CD monoclonal antibody mAb , which target two key immunoregulatory pathways that tumor cells exploit to evade the host immune system. SIRPaFc is an antibody like fusion protein that blocks the activity of CD , a molecule that is upregulated on tumor cells in acute myeloid leukemia AML and numerous other malignancies. The CD mAb is a fully human monoclonal antibody that blocks the activity of CD , an immunosuppressive molecule that is overexpressed by many hematopoietic and solid tumors.
Stock Information

Trillium Therapeutics Inc. Company Name:

TRIL Stock Symbol:

NASDAQ Market:

Trillium Therapeutics Inc. Website:

MENU
TRIL TRIL Quote TRIL Short TRIL News TRIL Articles TRIL Message Board
Get TRIL Alerts

News, Short Squeeze, Breakout and More Instantly...

Connect Twitter with Market Wire News
RECENT TRIL NEWS
  • TRIL - Why Investors Aren't Worried About Pfizer's Latest Failure

    In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...

  • TRIL - Trillium Therapeutics Receives Final Court Order Approving Arrangement

    CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...

  • TRIL - Trillium Securityholders Approve Acquisition by Pfizer

    CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that i...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email [email protected].

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected
Follow @MarketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News